Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00109-023-02372-x.

Title:
Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma | Journal of Molecular Medicine
Description:
Abstract This study aimed to analyze the clinical characteristics, cell types, and molecular characteristics of the tumor microenvironment to better predict the prognosis of neuroblastoma (NB). The gene expression data and corresponding clinical information of 498 NB patients were obtained from the Gene Expression Omnibus (GEO: GSE62564) and ArrayExpress (accession: E-MTAB-8248). The relative cell abundances were estimated using single-sample gene set enrichment analysis (ssGSEA) with the R gene set variation analysis (GSVA) package. We performed Cox regression analyses to identify marker genes indicating cell subsets and combined these with prognostically relevant clinical factors to develop a new prognostic model. Data from the E-MTAB-8248 cohort verified the predictive accuracy of the prognostic model. Single-cell RNA-seq data were analyzed by using the R Seurat package. Multivariate survival analysis for each gene, using clinical characteristics as cofactors, identified 34 prognostic genes that showed a significant correlation with both event-free survival (EFS) and overall survival (OS) (log-rank test, P value < 0.05). The pathway enrichment analysis revealed that these prognostic genes were highly enriched in the marker genes of NB cells with mesenchymal features and protein translation. Ultimately, USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP) (log-rank test, P value < 0.0001, median EFS: 640.5 vs. 2247 days, median OS: 1279.5 vs. 2519 days). The risk model was also regarded as a prognostic indicator independent of MYCN status, age, and stage. Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB. Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis. Key messages Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis. USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP). Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

pubmed, article, neuroblastoma, google, scholar, zhang, prognosis, cas, central, cancer, data, cell, prognostic, childrens, gene, analysis, tumor, yang, wang, microenvironment, usp, risk, beijing, clinical, model, group, signatures, cheng, genes, singlecell, oncol, huang, molecular, characteristics, poor, access, clin, liu, hospital, supplementary, information, research, wei, cox, survival, samples, nature, china, authors, university,

Topics {✒️}

month download article/chapter single-cell rna-seq data gene-centric approach identifies cell pyroptosis-related genes single-cell transcriptomics lmo1 super-enhancer polymorphism multimodal single-cell data immune-infiltrated tumor microenvironment triple-negative breast cancer muscle-invasive bladder cancer e-mtab-8248 cohort verified single-cell characterization gene expression omnibus gene expression data related subjects interpreting omics data single-cell atlas full article pdf moe key laboratory privacy choices/manage cookies irwin ms transcriptomic profiling high-risk neuroblastoma patients rna-seq era universal enrichment tool optimized cox model rna-seq data mesenchymal signature genes oldridge da relative cell abundances t-cell receptors improving risk stratification important prognostic marker prognostic indicator independent neuroblastoma cell lines p53/p21 pathway multivariate survival analysis high-risk mycn holds exclusive rights wenjun mou risk group classification human leukemia cells capital medical university article cheng human ovarian cancer pediatric oncology surgery article journal scrna-seq data european economic area predictive accuracy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma
         description:This study aimed to analyze the clinical characteristics, cell types, and molecular characteristics of the tumor microenvironment to better predict the prognosis of neuroblastoma (NB). The gene expression data and corresponding clinical information of 498 NB patients were obtained from the Gene Expression Omnibus (GEO: GSE62564) and ArrayExpress (accession: E-MTAB-8248). The relative cell abundances were estimated using single-sample gene set enrichment analysis (ssGSEA) with the R gene set variation analysis (GSVA) package. We performed Cox regression analyses to identify marker genes indicating cell subsets and combined these with prognostically relevant clinical factors to develop a new prognostic model. Data from the E-MTAB-8248 cohort verified the predictive accuracy of the prognostic model. Single-cell RNA-seq data were analyzed by using the R Seurat package. Multivariate survival analysis for each gene, using clinical characteristics as cofactors, identified 34 prognostic genes that showed a significant correlation with both event-free survival (EFS) and overall survival (OS) (log-rank test, P value &lt; 0.05). The pathway enrichment analysis revealed that these prognostic genes were highly enriched in the marker genes of NB cells with mesenchymal features and protein translation. Ultimately, USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP) (log-rank test, P value &lt; 0.0001, median EFS: 640.5 vs. 2247 days, median OS: 1279.5 vs. 2519 days). The risk model was also regarded as a prognostic indicator independent of MYCN status, age, and stage. Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB. Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis.
         datePublished:2023-09-15T00:00:00Z
         dateModified:2023-09-15T00:00:00Z
         pageStart:1421
         pageEnd:1436
         sameAs:https://doi.org/10.1007/s00109-023-02372-x
         keywords:
            Neuroblastoma
            Tumor microenvironment (TME)
            Mesenchymal features
            Cox model
            Prognosis
            Molecular Medicine
            Human Genetics
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig8_HTML.png
         isPartOf:
            name:Journal of Molecular Medicine
            issn:
               1432-1440
               0946-2716
            volumeNumber:101
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Haiyan Cheng
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Li Zhang
               affiliation:
                     name:Shanghai Jiao Tong University School of Medicine
                     address:
                        name:Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shen Yang
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qinghua Ren
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Saishuo Chang
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yaqiong Jin
               affiliation:
                     name:MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
                     address:
                        name:Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wenjun Mou
               affiliation:
                     name:Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
                     address:
                        name:Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hong Qin
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei Yang
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xianwei Zhang
               affiliation:
                     name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
                     address:
                        name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wancun Zhang
               affiliation:
                     name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
                     address:
                        name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huanmin Wang
               url:http://orcid.org/0000-0001-6769-9643
               affiliation:
                     name:National Center for Children’s Health
                     address:
                        name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma
      description:This study aimed to analyze the clinical characteristics, cell types, and molecular characteristics of the tumor microenvironment to better predict the prognosis of neuroblastoma (NB). The gene expression data and corresponding clinical information of 498 NB patients were obtained from the Gene Expression Omnibus (GEO: GSE62564) and ArrayExpress (accession: E-MTAB-8248). The relative cell abundances were estimated using single-sample gene set enrichment analysis (ssGSEA) with the R gene set variation analysis (GSVA) package. We performed Cox regression analyses to identify marker genes indicating cell subsets and combined these with prognostically relevant clinical factors to develop a new prognostic model. Data from the E-MTAB-8248 cohort verified the predictive accuracy of the prognostic model. Single-cell RNA-seq data were analyzed by using the R Seurat package. Multivariate survival analysis for each gene, using clinical characteristics as cofactors, identified 34 prognostic genes that showed a significant correlation with both event-free survival (EFS) and overall survival (OS) (log-rank test, P value &lt; 0.05). The pathway enrichment analysis revealed that these prognostic genes were highly enriched in the marker genes of NB cells with mesenchymal features and protein translation. Ultimately, USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP) (log-rank test, P value &lt; 0.0001, median EFS: 640.5 vs. 2247 days, median OS: 1279.5 vs. 2519 days). The risk model was also regarded as a prognostic indicator independent of MYCN status, age, and stage. Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB. Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis.
      datePublished:2023-09-15T00:00:00Z
      dateModified:2023-09-15T00:00:00Z
      pageStart:1421
      pageEnd:1436
      sameAs:https://doi.org/10.1007/s00109-023-02372-x
      keywords:
         Neuroblastoma
         Tumor microenvironment (TME)
         Mesenchymal features
         Cox model
         Prognosis
         Molecular Medicine
         Human Genetics
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-023-02372-x/MediaObjects/109_2023_2372_Fig8_HTML.png
      isPartOf:
         name:Journal of Molecular Medicine
         issn:
            1432-1440
            0946-2716
         volumeNumber:101
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Haiyan Cheng
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Li Zhang
            affiliation:
                  name:Shanghai Jiao Tong University School of Medicine
                  address:
                     name:Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shen Yang
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qinghua Ren
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Saishuo Chang
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yaqiong Jin
            affiliation:
                  name:MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
                  address:
                     name:Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wenjun Mou
            affiliation:
                  name:Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
                  address:
                     name:Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hong Qin
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei Yang
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xianwei Zhang
            affiliation:
                  name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
                  address:
                     name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wancun Zhang
            affiliation:
                  name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
                  address:
                     name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huanmin Wang
            url:http://orcid.org/0000-0001-6769-9643
            affiliation:
                  name:National Center for Children’s Health
                  address:
                     name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Molecular Medicine
      issn:
         1432-1440
         0946-2716
      volumeNumber:101
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:Shanghai Jiao Tong University School of Medicine
      address:
         name:Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
      address:
         name:Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
      address:
         name:Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
      name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
      address:
         name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
         type:PostalAddress
      name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
      address:
         name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
         type:PostalAddress
      name:National Center for Children’s Health
      address:
         name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Haiyan Cheng
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Li Zhang
      affiliation:
            name:Shanghai Jiao Tong University School of Medicine
            address:
               name:Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Shen Yang
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Qinghua Ren
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Saishuo Chang
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Yaqiong Jin
      affiliation:
            name:MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
            address:
               name:Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Wenjun Mou
      affiliation:
            name:Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health
            address:
               name:Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Hong Qin
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Wei Yang
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      name:Xianwei Zhang
      affiliation:
            name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
            address:
               name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
               type:PostalAddress
            type:Organization
      name:Wancun Zhang
      affiliation:
            name:Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital
            address:
               name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
               type:PostalAddress
            type:Organization
      name:Huanmin Wang
      url:http://orcid.org/0000-0001-6769-9643
      affiliation:
            name:National Center for Children’s Health
            address:
               name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
      name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
      name:Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children’s Malignant Tumors, Department of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, China
      name:Department of Surgical Oncology, MOE Key Laboratory of Major Diseases in Children, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(167)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.79s.